Pereira N - Search Results

1

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.

Avram R, So D, Iturriaga E, Byrne J, Lennon R, Murthy V, Geller N, Goodman S, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Olgin J, Pereira N. Avram R, et al. Among authors: pereira n. JMIR Form Res. 2022 Jun 13;6(6):e34080. doi: 10.2196/34080. JMIR Form Res. 2022. PMID: 35699977 Free PMC article.

2

A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.

Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, Rodeheffer RJ, Burnett JC Jr. Pereira NL, et al. PLoS One. 2014 Jan 22;9(1):e85708. doi: 10.1371/journal.pone.0085708. eCollection 2014. PLoS One. 2014. PMID: 24465655 Free PMC article.

3

Genotype-guided dosing of vitamin K antagonists.

Pereira NL, Rihal CS, Weinshilboum RM. Pereira NL, et al. N Engl J Med. 2014 May 1;370(18):1762. doi: 10.1056/NEJMc1402521. N Engl J Med. 2014. PMID: 24785216 No abstract available.

4

Genotype-based clinical trials in cardiovascular disease.

Pereira NL, Sargent DJ, Farkouh ME, Rihal CS. Pereira NL, et al. Nat Rev Cardiol. 2015 Aug;12(8):475-87. doi: 10.1038/nrcardio.2015.64. Epub 2015 May 5. Nat Rev Cardiol. 2015. PMID: 25940926 Free PMC article. Review.

5

Pharmacogenetics of Clopidogrel: An Unresolved Issue.

Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pereira NL, et al. Circ Cardiovasc Genet. 2016 Apr;9(2):185-8. doi: 10.1161/CIRCGENETICS.115.001318. Circ Cardiovasc Genet. 2016. PMID: 27094200 No abstract available.

6

Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

Borah BJ, Pereira N, Farkouh ME. Borah BJ, et al. Among authors: pereira n. Cardiovasc Drugs Ther. 2017 Feb;31(1):1-3. doi: 10.1007/s10557-017-6720-7. Cardiovasc Drugs Ther. 2017. PMID: 28251381 No abstract available.

7

Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.

Arendt CJ, Hong JH, Daly RC, Scott C, Mehta RA, Bailey K, Pathak J, Pereira NL. Arendt CJ, et al. Am Heart J. 2017 May;187:70-77. doi: 10.1016/j.ahj.2017.02.011. Epub 2017 Feb 16. Am Heart J. 2017. PMID: 28454810

8

Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation.

Asleh R, Prasad M, Briasoulis A, Nardi V, Adigun R, Edwards BS, Pereira NL, Daly RC, Lerman A, Kushwaha SS. Asleh R, et al. J Heart Lung Transplant. 2018 Sep;37(9):1083-1092. doi: 10.1016/j.healun.2018.04.017. Epub 2018 May 1. J Heart Lung Transplant. 2018. PMID: 29802086

9

Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.

Asleh R, Briasoulis A, Pereira NL, Boilson BA, Edwards BS, Adigun R, Maltais S, Daly RC, Lerman A, Kushwaha SS. Asleh R, et al. ESC Heart Fail. 2018 Dec;5(6):1118-1129. doi: 10.1002/ehf2.12329. Epub 2018 Jul 17. ESC Heart Fail. 2018. PMID: 30019530 Free PMC article.

10

Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients.

Asleh R, Briasoulis A, Pereira NL, Edwards BS, Frantz RP, Daly RC, Lerman A, Kushwaha SS. Asleh R, et al. J Heart Lung Transplant. 2018 Nov;37(11):1372-1380. doi: 10.1016/j.healun.2018.07.004. Epub 2018 Aug 30. J Heart Lung Transplant. 2018. PMID: 30174165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,125 results

Search Page